Crossmark

Upadacitinib: un nuevo fármaco rápido y efectivo en el tratamiento de la dermatitis atópica

Crossref DOI link: https://doi.org/10.1016/j.piel.2024.01.020

Published Print: 2024-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mansilla-Polo, Miguel

Navarro-Mira, Miguel Ángel

Martín-Torregrosa, Daniel

Botella-Estrada, Rafael
License Information

Text and Data Mining valid from 2024-08-01

Text and Data Mining valid from 2024-08-01

stm-asf valid from 2024-08-01

stm-asf valid from 2024-08-01

stm-asf valid from 2024-08-01

stm-asf valid from 2024-08-01

stm-asf valid from 2024-08-01
More Information

This article is maintained by: Elsevier

Article Title: Upadacitinib: un nuevo fármaco rápido y efectivo en el tratamiento de la dermatitis atópica

Journal Title: Piel

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.piel.2024.01.020

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.